Collaboration and innovation shine at the Maddie Riewoldt’s Vision National Symposium on Bone Marrow Failure Syndromes

On October 13-15, the Maddie Riewoldt’s Vision Centre of Research Excellence in Bone Marrow Biology was proud to host the 3rd National Symposium on Bone Marrow Failure Syndromes.

It was an occasion like no other, brimming with collaboration, inspiration, and innovation. The symposium brought together international and national experts who shared their cutting-edge research, insights, and experiences, paving the way for the next generation of discoveries to prevent, diagnose and treat Bone Marrow Failure Syndromes.

The symposium launched with a Welcome Reception and Expert Panel session, generously hosted by Perpetual. This event was a fantastic opportunity for symposium delegates to network and mingle with their peers, including patients and families who attended to learn more about the latest in Bone Marrow Failure Syndrome research.

Over the course of the weekend, the Victorian Comprehensive Cancer Centre (VCCC) was abuzz with a high calibre program of scientific, clinical, and case study presentations. This year, we were thrilled to welcome esteemed international speakers Professor Rodrigo T. Calado (Chair, Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeirão Preto School of Medicine, University of São Paulo) and Dr Sharon Savage (Clinical Director, Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA) along with 28 national speakers sharing their groundbreaking research.

Feedback from this year’s symposium has been overwhelmingly positive, with guests sharing their satisfaction with the variety of scientific, clinical and case study content:

‘Good sized audience. Excellent international speakers. Excellent mix of presentations. I felt like many of the bone marrow failure experts in Australia were in the room. Great to have an in-person symposium that supported networking. It was a really enjoyable and informative program.’

‘Fantastic breadth of topics (basic science, translation, gene therapy, clinical adult/paediatrics, immune and inherited bone marrow failure, non-haematology manifestations), plus a predominantly local/emerging research focus rather than a “big pharma” focus. Very collaborative meeting that fostered discussion among all attendees. One of the best meetings i have ever attended!’

‘The fact that the entire country’s Bone Marrow Failure research field gets together in a collaborative environment with less reservation about sharing preliminary data is unique amongst national conferences.’

We are thrilled that new connections have been made with the promise of future scientific collaborations and exchanges of knowledge, and can’t wait to see what the future holds for Bone Marrow Failure Syndrome research.

Thank you to our generous symposium partners for their valued support